F&V Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $15.3M | Sell |
176,322
-230
| -0.1% | -$22K | 3.23% | 13 |
|
|
2025
Q4 | $17M | Sell |
176,552
-2,209
| -1% | -$215K | 3.61% | 12 |
|
|
2025
Q3 | $17M | Buy |
178,761
+791
| +0.4% | +$72.7K | 3.82% | 11 |
|
|
2025
Q2 | $15.5M | Sell |
177,970
-1,915
| -1% | -$162K | 3.96% | 10 |
|
|
2025
Q1 | $16.2M | Buy |
179,885
+2,890
| +2% | +$259K | 4.2% | 8 |
|
|
2024
Q4 | $14.1M | Sell |
176,995
-180
| -0.1% | -$15.6K | 3.72% | 12 |
|
|
2024
Q3 | $16M | Buy |
177,175
+700
| +0.4% | +$58.9K | 4.1% | 11 |
|
|
2024
Q2 | $13.9M | Buy |
176,475
+9,395
| +6% | +$770K | 4.05% | 10 |
|
|
2024
Q1 | $14.6M | Buy |
167,080
+2,000
| +1% | +$171K | 4.29% | 7 |
|
|
2023
Q4 | $13.6M | Buy |
165,080
+2,260
| +1% | +$172K | 4.36% | 6 |
|
|
2023
Q3 | $12.8M | Sell |
162,820
-735
| -0.4% | -$61.5K | 4.37% | 7 |
|
|
2023
Q2 | $14.4M | Sell |
163,555
-835
| -0.5% | -$71.9K | 4.65% | 5 |
|
|
2023
Q1 | $13.3M | Buy |
164,390
+85,235
| +108% | +$6.95M | 4.4% | 7 |
|
|
2022
Q4 | $6.15M | Buy |
79,155
+825
| +1% | +$66.9K | 2.05% | 22 |
|
|
2022
Q3 | $6.33M | Sell |
78,330
-2,060
| -3% | -$185K | 2.44% | 22 |
|
|
2022
Q2 | $7.21M | Buy |
80,390
+2,315
| +3% | +$235K | 2.57% | 23 |
|
|
2022
Q1 | $8.66M | Buy |
78,075
+1,405
| +2% | +$148K | 2.63% | 21 |
|
|
2021
Q4 | $7.93M | Buy |
76,670
+9,120
| +14% | +$1.06M | 2.66% | 24 |
|
|
2021
Q3 | $8.47M | Buy |
67,550
+310
| +0.5% | +$40.1K | 3.39% | 15 |
|
|
2021
Q2 | $8.35M | Buy |
67,240
+795
| +1% | +$99.8K | 3.07% | 18 |
|
|
2021
Q1 | $7.85M | Buy |
66,445
+785
| +1% | +$92K | 2.93% | 14 |
|
|
2020
Q4 | $7.69M | Buy |
65,660
+870
| +1% | +$95.8K | 3.32% | 10 |
|
|
2020
Q3 | $6.73M | Sell |
64,790
-640
| -1% | -$64.3K | 3.27% | 11 |
|
|
2020
Q2 | $6M | Buy |
65,430
+1,990
| +3% | +$191K | 3.04% | 16 |
|
|
2020
Q1 | $5.72M | Buy |
63,440
+2,780
| +5% | +$296K | 3.64% | 9 |
|
|
2019
Q4 | $6.88M | Sell |
60,660
-760
| -1% | -$83.4K | 3.73% | 5 |
|
|
2019
Q3 | $6.67M | Sell |
61,420
-410
| -0.7% | -$42.8K | 4.13% | 5 |
|
|
2019
Q2 | $6.02M | Sell |
61,830
-1,620
| -3% | -$148K | 3.59% | 12 |
|
|
2019
Q1 | $5.78M | Sell |
63,450
-2,660
| -4% | -$238K | 3.3% | 14 |
|
|
2018
Q4 | $6.01M | Buy |
66,110
+520
| +0.8% | +$48.6K | 3.64% | 9 |
|
|
2018
Q3 | $6.45M | Buy |
65,590
+35
| +0.1% | +$3.24K | 3.47% | 12 |
|
|
2018
Q2 | $5.61M | Sell |
65,555
-3,515
| -5% | -$294K | 3.22% | 14 |
|
|
2018
Q1 | $5.54M | Buy |
69,070
+350
| +0.5% | +$28.9K | 3.02% | 13 |
|
|
2017
Q4 | $5.55M | Sell |
68,720
-2,880
| -4% | -$231K | 2.88% | 14 |
|
|
2017
Q3 | $5.57M | Buy |
71,600
+25
| +0% | +$2.08K | 3.26% | 15 |
|
|
2017
Q2 | $6.35M | Sell |
71,575
-500
| -0.7% | -$42.2K | 3.6% | 8 |
|
|
2017
Q1 | $5.81M | Buy |
72,075
+27,640
| +62% | +$2.16M | 3.37% | 9 |
|
|
2016
Q4 | $3.17M | Buy |
44,435
+1,255
| +3% | +$98.6K | 1.99% | 24 |
|
|
2016
Q3 | $3.73M | Buy |
43,180
+260
| +0.6% | +$22.7K | 2.58% | 20 |
|
|
2016
Q2 | $3.72M | Sell |
42,920
-325
| -0.8% | -$26.3K | 2.77% | 18 |
|
|
2016
Q1 | $3.24M | Sell |
43,245
-3,905
| -8% | -$294K | 2.55% | 19 |
|
|
2015
Q4 | $3.63M | Sell |
47,150
-1,000
| -2% | -$75.3K | 2.64% | 17 |
|
|
2015
Q3 | $3.22M | Buy |
48,150
+10,750
| +29% | +$792K | 2.29% | 21 |
|
|
2015
Q2 | $2.77M | Buy |
37,400
+985
| +3% | +$75.3K | 1.88% | 25 |
|
|
2015
Q1 | $2.84M | Buy |
36,415
+5,070
| +16% | +$384K | 1.93% | 24 |
|
|
2014
Q4 | $2.26M | Buy |
+31,345
| New | +$2.18M | 1.54% | 28 |
|
Other funds holding MDT
VCM
VPM
F&V Capital Management's MDT Position: Q1 2026 in Review
F&V Capital Management reduced its Medtronic (MDT) stake by 0.13% in Q1 2026, selling an estimated $22K and leaving 176,322 shares worth $15.3M. The position accounts for 3.23% of the portfolio, ranked #13.
F&V Capital Management first reported a position in MDT in Q4 2014 and has held it in 46 quarters since. The position peaked at $17M in Q3 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- F&V Capital Management held 176,322 shares of Medtronic worth $15.3M as of Q1 2026.
- F&V Capital Management sold 230 Medtronic shares in Q1 2026, an estimated $22K.
- Medtronic made up 3.23% of F&V Capital Management's portfolio in Q1 2026, its #13 holding.
- F&V Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 46 quarters since.
- F&V Capital Management's Medtronic position peaked at $17M in Q3 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on F&V Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.